Mindera Health™ Signs Contract with Nationwide Provider Network MediNcrease™
03. Oktober 2023 10:00 ET
|
Mindera Health
San Diego, CA, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Mindera Health™ today announces the signing of a network provider contract with MediNcrease Health Plans, a national provider network and provider...
Mindera Health™ Announces Change to Executive Leadership Team
11. Mai 2023 15:57 ET
|
Mindera Health
San Diego, CA, May 11, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has announced a change in its executive...
Mindera Health™ Announces Coverage with Evidence Project with Highmark, Inc. to Advance Moderate-to-Severe Psoriasis Patient Care and Reduce Specialty Drug Spending
11. April 2023 09:00 ET
|
Mindera Health
San Diego, CA, April 11, 2023 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of Mind.Px, the first realization of precision medicine in psoriasis, has initiated a coverage with evidence project...
Mindera Health™ Appoints Linh H. Le as Chief Financial Officer and Chief Operating Officer
14. März 2023 08:00 ET
|
Mindera Health
San Diego, CA, March 14, 2023 (GLOBE NEWSWIRE) -- Mindera Health, the developer of Mind.Px™, the first realization of precision medicine in psoriasis, has appointed Mr. Linh H. Le as Chief Financial...
Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients
20. Oktober 2022 08:00 ET
|
Mindera Health
San Diego, CA, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Interim clinical utility and patient outcomes data regarding Mindera Health’s Mind.Px™ test from the ongoing MATCH study were recently presented at...
Mindera Health™ Launches Pilot with National Health Insurance Company to Improve Management of Moderate-To-Severe Psoriasis Patients Through Precision Medicine
28. April 2022 08:00 ET
|
Mindera Health
San Diego, CA, April 28, 2022 (GLOBE NEWSWIRE) -- Mindera Health™, the developer of the groundbreaking Dermal Intelligence™ platform - the first realization of precision medicine in psoriasis, has...
Mindera Health™ Appoints Ted St. Martin as Chief Financial Officer
10. März 2022 08:00 ET
|
Mindera Health
San Diego, CA, March 10, 2022 (GLOBE NEWSWIRE) -- Mindera Health™, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of precision medicine in psoriasis, ...
Mindera Health™ Appoints Deborah L. Rice-Johnson to its Board of Directors
01. März 2022 08:00 ET
|
Mindera Health
San Diego, CA, March 01, 2022 (GLOBE NEWSWIRE) -- Mindera Health™, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of personalized medicine in...
Mindera Health™ and WellDyne announce a definitive agreement to improve management of moderate-to-severe psoriasis patients
04. Januar 2022 11:00 ET
|
Mindera Health
SAN DIEGO, CA and LAKELAND, FL, Jan. 04, 2022 (GLOBE NEWSWIRE) -- Mindera Health™ and WellDyne have entered into a definitive agreement to improve the management of psoriasis patients with moderate...
Mindera Health™ announces publication of positive results from STAMP-1 and STAMP-2 studies
16. November 2021 11:30 ET
|
Mindera Health
San Diego, CA, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Mindera Health™, developers of the ground-breaking Dermal Intelligence™ platform that is the first realization of personalized medicine in psoriasis,...